Weight-loss drugs like Ozempic may also curb drug and alcohol addiction
Short excerpt below. Click through to read at the original source.
GLP-1 drugs, originally developed for diabetes and obesity, may also curb addictive behaviors by acting on reward circuits in the brain. Early trials show reductions in alcohol intake, opioid seeking, and nicotine use. Though more research is needed, scientists believe these drugs could open a powerful new front in addiction therapy.